{
    "nct_id": "NCT05132205",
    "official_title": "Radiofrequency Ablation of Papillary Thyroid Microcarcinoma",
    "inclusion_criteria": "* All patients regardless of sex or race between the ages 18-100 with biopsy proven PTMC with a Bethesda V or VI pathology or indeterminate cytology on fine-needle aspiration cytology (FNAC) who are recommended for treatment (Bethesda III/IV).\n* Solitary thyroid nodule <20mm in maximal dimension.\n* No sonographic evidence of extrathyroidal invasion, lymph node metastases, or distant metastases.\n* There must be at least 1 mm of normal tissue as a margin, without sonographic evidence of contact with the capsule.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 100 Years",
    "exclusion_criteria": "* Patients with other histological types of thyroid malignancy other than papillary thyroid cancer such as medullary carcinoma, Proto-oncogene serine/threonine kinase (BRAF) or Telomerase reverse transcriptase (TERT) mutations\n* Clinically apparent multicentricity\n* Lesions larger than 20 mm in maximum diameter.\n* Recurrent laryngeal nerve palsy.\n* Extension of nodule to posterior thyroid capsule.\n* Ultrasound or other imaging studies revealing cervical lymph node involvement or distant metastases.\n* Pregnancy.\n* Pacemaker.\n* Previous RFA.",
    "miscellaneous_criteria": ""
}